Doximity, Inc. (DOCS) Stock Price & Analysis

Doximity, Inc. (DOCS) fell 0.15% to USD 20.42 as of July 25, 2026 at 02:24 UTC, according to Nexqual real-time market data.

DOCS last closed at USD 20.45; the session ranged USD 20.35–21 on volume of 1,784,752 shares. Market capitalization is $3.67B, with a 52-week range of USD 17.15–76.51 (NYQ). Source: Nexqual, July 25, 2026 at 02:24 UTC.

Key Statistics (as of July 25, 2026 at 02:24 UTC)

Technical Analysis (DOCS)

Nexqual's technical model rates DOCS "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 02:24 UTC.

Analyst Ratings (DOCS)

Wall Street analysts rate DOCS "Buy" based on 18 analysts, with a mean price target of USD 24.61 (range USD 18–42), per Nexqual as of July 25, 2026 at 02:24 UTC.

Earnings (DOCS)

Recent Earnings History

Source: Nexqual, July 25, 2026 at 02:24 UTC.

Financials & Fundamentals (DOCS)

Source: Nexqual, July 25, 2026 at 02:24 UTC.

Financial Health Score (DOCS)

Nexqual rates Doximity, Inc.'s overall financial health "Strong" across five dimensions, as of July 25, 2026 at 02:24 UTC.

Ownership (DOCS)

Source: Nexqual, July 25, 2026 at 02:24 UTC.

Leadership (DOCS)

Doximity, Inc. is led by Jeffrey A. Tangney (age 52), Co-Founder, CEO & Chairperson, per Nexqual as of July 25, 2026 at 02:24 UTC.

Major Backers & Investors (DOCS)

Notable institutional backers of Doximity, Inc. include ClearBridge Investments, LLC, William Blair Investment Management, LLC, Carmignac Gestion, according to Nexqual as of July 25, 2026 at 02:24 UTC.

Active Investors

Index Funds (Passive)

Source: Nexqual, July 25, 2026 at 02:24 UTC.

From Doximity, Inc.'s Latest SEC 10-K Filing (filed 2026-05-19)

Key Strengths & Strategy (as disclosed to the SEC)

• The product is HIPAA-compliant for all users, with data encrypted in transit and at rest. 7 Table of Contents Clinical AI Suite for Hospitals and Health Systems Doximity's Clinical AI Suite brings together Ask, Scribe, and Dialer into a unified, AI-powered workflow that supports clinical communication, documentation, and fast, evidence-backed answers to clinical questions.
• Overview We are the leading physician-first tech company, with over 3 million registered members 1 as of March 31, 2026.
• Once verified, members gain access to our network, newsfeed, and—depending on their credentials—our Clinical AI Suite, including Dialer, our voice and video telehealth product; Scribe, our ambient AI that listens during patient visits and generates structured notes; and Ask (formerly DoxGPT), which provides evidence-based answers to clinical questions, including drug information.
• For example, the laws of the State of California, in which we operate, are more restrictive than HIPAA, including the provisions of the California Consumer Privacy Act and the California Privacy Act.

Partnerships

• Specifically, we compete for medical professionals as platform members, and for pharmaceutical and health system companies as customers for our Marketing, Hiring, and Workflow Solutions. • Competing for members: We compete with large technology companies that have developed online networking and collaboration tools such as LinkedIn, Facebook, Google, and X, in addition to smaller, emerging companies.
• Patients can search for the right doctor or hospital for their needs through our collaboration with the Doctor Finder tool of U.S.

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 02:24 UTC. This page is informational and not investment advice.